ATS Foundation Website: Donation Made Easy!
Designed with user experience in mind, the ATS Foundation launched a new website in 2019! Seeking to be engaging and accessible to ATS members in addition to a wider audience of patients and caregivers alike, the new website is intuitive for any visitors who’d like to partner with the Foundation or share their stories of receiving a research grant. We’ve even made it easier to donate!
The ATS Foundation is looking forward to welcoming new visitors, sharing stories of patients and highlighting the successes of our researchers. As the Foundation continues to grow, the website will showcase its work and make it simple for supporters to help make an impact.
The ATS Foundation is the philanthropic arm of the American Thoracic Society. Established in 2004, it invests in talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
Reminder! Assembly on Allergy, Immunology & Inflammation Announces Journal Club Tomorrow
The next Journal Club (JC) meeting for the Assembly on Allergy, Immunology, and Inflammation (AII) will feature the article, “Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches,” which appeared in the March 19, 2019 issue of Immunity.
Authors Madelene Dahlgren, PhD, and Ari Molofsky, MD, PhD, will participate in the discussion, as well as Andrew Luster, MD, PhD. Rod Rahimi, MD, PhD will moderate.
The session will be recorded and posted on the ATS website. Please contact Dr. Rahimi with any questions.
When: 12 p.m. EST, Thursday, July 18, 2019
Where: Online. Register now!
Reminder! Twitter Chat Tomorrow
Join the ATS and David J. Feller-Kopman, MD (@dfellerk) for a Twitter chat! Dr. Feller-Kopman will discuss “ Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
When: 1 p.m. EST, July 18, 2019
Where: Online, using the hashtag #ATSchat.
World Lung Day
World Lung Day is recognized annually on Sept. 25. This year’s theme is “healthy lungs for all,” calling for Universal Health Coverage (UHC).
Universal coverage is particularly important in regards to respiratory disease. A break in the supply of medicine for a patient with tuberculosis could cause the development of drug resistance. The abrupt unavailability of asthma medicine could cause severe suffering and even death. Lack of health care provider availability usually means delay in diagnosis, which could be fatal for lung cancer patients.
The global spotlight on UHC represents an opportunity for substantial progress in the fight against lung disease around the world.
This World Health Day, the Forum of International Respiratory Societies is asking the lung health community to raise awareness of the burden of respiratory disease, and advocate for UHC.
COPD/Sleep Apnea Overlap Syndrome Researcher Awarded $100,000 Grant from ResMed, ATS Foundation
David Geoffrey Chapman, BSc, PhD, of University of Technology in Sydney, Australia, has been awarded the new ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy.
Dr. Chapman’s $100,000 award will support his research into how non-invasive ventilation (NIV) can help improve sleep for people with both obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), known as COPD/OSA Overlap Syndrome.
Specifically, Chapman will determine how effective various NIV settings are in addressing hyperinflation, the act of breathing at abnormally high lung volumes that is common in people with COPD. Hyperinflation reduces the function of the diaphragm, the predominant muscle for breathing during sleep, and is correlated to reduced sleep quality in a pilot study, also by Chapman.
Read more!
